Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.4 - $1.09 $10,849 - $29,565
-27,124 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$1.63 - $3.43 $6,288 - $13,232
-3,858 Reduced 12.45%
27,124 $48,000
Q2 2021

Aug 16, 2021

SELL
$4.78 - $6.84 $28,364 - $40,588
-5,934 Reduced 16.07%
30,982 $174,000
Q1 2021

May 17, 2021

BUY
$5.9 - $9.13 $4,088 - $6,327
693 Added 1.91%
36,916 $249,000
Q4 2020

Feb 16, 2021

BUY
$3.0 - $6.71 $29,937 - $66,959
9,979 Added 38.02%
36,223 $243,000
Q3 2020

Nov 16, 2020

BUY
$2.54 - $4.56 $24,053 - $43,183
9,470 Added 56.46%
26,244 $81,000
Q2 2020

Aug 14, 2020

BUY
$0.78 - $5.25 $13,083 - $88,063
16,774 New
16,774 $64,000

Others Institutions Holding AWH

About Aspira Women's Health Inc.


  • Ticker AWH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 124,296,000
  • Market Cap $123M
  • Description
  • Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...
More about AWH
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.